IDO levels are increased in the hippocampus of AD patients (Guillemin et al., 2005a), and INF-ɣ and IDO levels are increased in the cerebrum of female triple transgenic mice (3xTg-AD), a commonly used model of AD (Fertan et al., 2019a). Here, CBLIF is linked to Alzheimer disease.